UPDATE
: 2024.7.1 ¿ù 18:01
óÀ½À¸·Î
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
Áö¸éº¸±â
Æ®À§ÅÍ
ÆäÀ̽ººÏ
RSS
´º½º
½ÃÀåÀ̽´
½ÃȲ
°ø½Ã
±â¾÷¸®Æ÷Æ®
·ç¸Ó&Áø½Ç
ÁÖ°£ ÇÖ À̽´
»ç¶÷µé
Àλç
ºÎÀ½
°áÈ¥
Çà»ç
½ÅÁ¦Ç°
ÀÚ·á½Ç
ÀÚ·á½Ç
±â»ç°Ë»ö
±¸µ¶½Åû
Àüü±â»çº¸±â
¸ð¹ÙÀÏÀ¥
»ó´Ü¿©¹é
񃯇
(Àüü 4,555°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
¼¼¿î¸ÞµðÄ®,¼ºÀå Áغñ ¿Ï·á
¹Úº´¿ì ±âÀÚ
|
2018-08-24 08:31
¶óÀÎ
ÇコÄɾî Daily(8/24)-½ÅÇѱÝÀ¶ÅõÀÚ
¹Úº´¿ì ±âÀÚ
|
2018-08-24 08:26
¶óÀÎ
°£¼¼Æ÷¾Ï Ä¡·á Á¦ ³Ø»ç¹Ù¿¡ ´ëÇ×ÇÏ´Â ·»ºñ¸¶, FDAÇã°¡(±è¹ÌÇö AnalystÀÇ Bio insight)
¹Úº´¿ì ±âÀÚ
|
2018-08-23 08:21
¶óÀÎ
ÇコÄɾî Daily(8/23)-½ÅÇѱÝÀ¶ÅõÀÚ
¹Úº´¿ì ±âÀÚ
|
2018-08-23 08:14
¶óÀÎ
¾ÆÀ̼¾½º, Downside risk Á¦ÇÑÀû
¹Úº´¿ì ±âÀÚ
|
2018-08-23 08:12
¶óÀÎ
Á¦¾à/¹ÙÀÌ¿À,¹Ì±¹ 7 ¿ù ¹ÙÀÌ¿À½Ã¹Ð·¯ ó¹æµ¥ÀÌÅÍ
±è»ç¶û ±âÀÚ
|
2018-08-22 09:47
¶óÀÎ
Á¦¾à-SK Pharma Weekly(8/16~21)
±è»ç¶û ±âÀÚ
|
2018-08-22 09:10
¶óÀÎ
ÇコÄɾî Daily(8/22-½ÅÇѱÝÀ¶ÅõÀÚÁõ±Ç)
±è»ç¶û ±âÀÚ
|
2018-08-22 09:04
¶óÀÎ
ÈÞÁ©, ÇØ¿Ü NDR Èıâ
¹Úº´¿ì ±âÀÚ
|
2018-08-22 08:50
¶óÀÎ
Á¦¾à/¹ÙÀÌ¿À,ÃÖ´ë ¾ÇÀç¿´´ø R&D ȸ°è À̽´, Å« °íºñ ³Ñ°å´Ù
¹Úº´¿ì ±âÀÚ
|
2018-08-21 08:28
¶óÀÎ
ÇコÄɾî Daily(8/21)-½ÅÇѱÝÀ¶ÅõÀÚ
¹Úº´¿ì ±âÀÚ
|
2018-08-21 08:22
¶óÀÎ
¸¶Å©·ÎÁ¨, ÁÖ°¡ ±Þµî°ü·Ã ÄÚ¸àÆ®
±è»ç¶û ±âÀÚ
|
2018-08-21 08:20
¶óÀÎ
[Á¦¾à/¹ÙÀÌ¿À] ¾ÆÀÌ ¸Ó´Ï(Eye-Money) : µ·ÀÌ µÇ´Â ¾È°ú½ÃÀå
¹Úº´¿ì ±âÀÚ
|
2018-08-21 07:26
¶óÀÎ
»ïõ´çÁ¦¾à, Àǽɿ¡¼ ¹ÏÀ½À¸·Î
±è»ç¶û ±âÀÚ
|
2018-08-21 06:56
¶óÀÎ
¾ËÅ׿ÀÁ¨, ½ÃÀå¼±Åðú °øµ¿°³¹ß·Î ¼º°øÈ®·üÀ» ³ôÀδÙ
¹Úº´¿ì ±âÀÚ
|
2018-08-21 06:52
¶óÀÎ
·çÆ®·Î´Ð, »õ·Î¿î ½ÃÀå¿¡ ´ëÇÑ Áغñ
¹Úº´¿ì ±âÀÚ
|
2018-08-21 06:47
¶óÀÎ
¾ÆÀÌÁø, ºñÁõ½Ä¼º ´ç´¢¸Á¸·Áõ(NPDR) Ä¡·áÁ¦¿¡ ´Ù½Ã ÁÖ¸ñÇÒ ½ÃÁ¡
¹Úº´¿ì ±âÀÚ
|
2018-08-21 06:42
¶óÀÎ
¿¤¾ØÄÉÀ̹ÙÀÌ¿À, ½Å±Ô½ÃÀå ÁøÃâ·Î Áö¼Ó¼ºÀå
¹Úº´¿ì ±âÀÚ
|
2018-08-20 10:01
¶óÀÎ
¿£ÁöÄÍ»ý¸í°úÇÐ,¸ð¸àÅÒµéÀÌ ´Ù°¡¿À°í ÀÖ´Ù
±è»ç¶û ±âÀÚ
|
2018-08-20 08:41
¶óÀÎ
´ë¿õÁ¦¾à,³ªº¸Å¸(DWP-450) ij³ª´Ù Çã°¡ ¼º°ø!
±è»ç¶û ±âÀÚ
|
2018-08-20 08:36
-
ÀÌÀü
181
182
183
184
185
186
187
188
189
190
´ÙÀ½
-
¿©¹é
¿À´ÃÀÇ
ÁÖ¿ä´º½º
[°ø½Ã]
ºñÇǵµ, Ⱦ·É¤ý¹èÀÓ ÇøÀÇ ÁøÇà»çÇ×
[½ÅÁ¦Ç°]
ȯÀÎÁ¦¾à, ¾ËÃ÷ÇÏÀÌ¸Ó Ä¡·áÁ¦ ȯÀθ޸¸Æ¾¿ÀµðÁ¤
[°ø½Ã]
SKÄɹÌÄ®, ºÒ¼º½Ç°ø½Ã¹ýÀÎ ÁöÁ¤¿¹°í
[°ø½Ã]
¿¤¾Ø¾¾¹ÙÀÌ¿À, Àüȯ°¡¾×ÀÇ Á¶Á¤
¿©¹é
¸¹ÀÌ º»
´º½º
01.
»þÆä·Ð, ¼¼Æ÷µ¶¼º ¾Ë°í¸®Áò Á¤È®µµ 92% ´Þ¼º..½Å¾à°³¹ß È¿À²¼º ±Ø´ëÈ
02.
ÇÏÀÌÆÛÄÚÆÛ·¹À̼Ç, ¹ÙÀÌ¿À¿¡¼ ±Û·Î¹ú ¶óÀÌÇÁ AI ¼Ö·ç¼Ç ±â¾÷ ÀçÆí
03.
Å¥¸®¿Á½º,¹Ì±¹ ½ºÅÄÆÛµå ´ëÇп¡ 'Pluto LT ½Ã½ºÅÛ' Çõ½Å ¼¾ÅÍ °³¼³
04.
SK¹ÙÀÌ¿À»çÀ̾ð½º, ±Û·Î¹ú TOP 10 µ¶ÀÏ ¹é½Å CMO±â¾÷ Àμö
05.
¿¤¾ØÄÉÀ̹ÙÀÌ¿À, 'ÇÁ¸®½ÃÁ𠽺ÆÄÀÎ'°ú ´ë¸®Á¡ °è¾à...Ú¸ ½ÃÀå °ø·«
06.
¸ÞµðÅ彺, Çмú±³À° ÇÁ·Î±×·¥ ¡®M.LAB¡¯ ù Çà»ç ¼º·á
07.
¹ÙÀÌ¿À´Ï¾Æ, ±â¾÷¼³¸íȸ(IR) °³ÃÖ
08.
Áö¾¾¼¿, 2Á¶¿ø ±Ô¸ð CAR-NK °øµ¿¿¬±¸ °è¾à ÇØÁö
09.
±¹³» ÀǾàÇ° ½ÃÀå 31Á¶ 4,513¾ï¿ø...'¿ª´ëÃÖ°í'
10.
Å׶ó»çÀ̾ð½º, ȸ»ýÀýÂ÷ °³½Ã½Åû/ÁֱǸŸŰŷ¡Á¤Áö ±â°£º¯°æ
¿©¹é
Back to Top